Pancreatic Cancer Research

ResearcherNagoya City UniversityNo recent work listed

Goro Ueda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1287-4031; OpenAlex author ID A5110810905. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 6

  1. Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines. Co-author DOI 10.3892/or.2023.8606↗
  2. 10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines. Co-author DOI 10.3892/or.2022.8259↗
  3. Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer. Co-author DOI 10.3892/or.2022.8279↗
  4. Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreat… Co-author DOI 10.3892/or.2021.8006↗
  5. Acquisition of gemcitabine resistance enhances angiogenesis via upregulation of IL‑8 production in pancreatic cancer. Co-author DOI 10.3892/or.2019.7105↗
  6. [A Case of Conversion Surgery for an Initially Locally Advanced Unresectable Pancreatic Cancer after S-1 Chemotherapy]. Co-author PMID 32156996↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kan Omi · 6 shared papers, 2019–2023 · strength 0.70
  2. Hiroyuki Imafuji · 6 shared papers, 2019–2023 · strength 0.70
  3. Yuichi Hayashi · 6 shared papers, 2019–2023 · strength 0.70
  4. Yoichi Matsuo · 6 shared papers, 2019–2023 · strength 0.70
  5. Shuji Takiguchi · 6 shared papers, 2019–2023 · strength 0.70
  6. Mamoru Morimoto · 6 shared papers, 2019–2023 · strength 0.70
  7. Hiroki Takahashi · 6 shared papers, 2019–2023 · strength 0.70
  8. Kenta Saito · 6 shared papers, 2019–2023 · strength 0.70
  9. Tomokatsu Kato · 4 shared papers, 2021–2023 · strength 0.53
  10. Hiromichi Murase · 3 shared papers, 2022–2023 · strength 0.41
  11. Keisuke Nonoyama · 1 shared paper, 2023 · strength 0.15
  12. Yuki Denda · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.